MoonLake regains momentum after the FDA Type B meeting allows BLA submission for sonelokimab in HS without additional trials.
Examination of transdermal berberine delivery, GLP-1 pathway terminology in supplement marketing, and consumer evaluation ...
Aurora Therapeutics, cofounded by Nobel Prize–winning scientist Jennifer Doudna, plans to use gene editing and a new FDA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback